1. Signaling Pathways
  2. Apoptosis
  3. Bcl-2 Family

Bcl-2 Family (Bcl-2蛋白家族)

Bcl-2 是一个进化相关的蛋白质家族。这些蛋白质控制线粒体外膜通透性 (MOMP),可以是促凋亡的(Bax、Bad、Bak 和 Bok 等),也可以是抗凋亡的(包括 Bcl-2 本身、Bcl-xL 和 Bcl-w 等)。迄今为止,Bcl-2 家族中已知的基因共有 25 个。编码属于该家族的蛋白质的人类基因包括:Bak1、Bax、Bal-2、Bok、Mcl-1。

Bcl-2 is a family of evolutionarily related proteins. These proteins govern mitochondrial outer membrane permeabilization (MOMP) and can be either pro-apoptotic (Bax, Bad, Bak and Bok among others) or anti-apoptotic (including Bcl-2 proper, Bcl-xL, and Bcl-w, among an assortment of others). There are a total of 25 genes in the Bcl-2 family known to date. Human genes encoding proteins that belong to this family include: Bak1, Bax, Bal-2, Bok, Mcl-1.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0087R
    Gambogic Acid (Standard)

    藤黄酸 (Standard)

    Inhibitor
    Gambogic Acid (Standard) 是 Gambogic Acid 的分析标准品。本产品用于研究及分析应用。Gambogic Acid (Beta-Guttiferrin) 来自 Garcinia hanburyi 树的藤黄树脂。Gambogic Acid (Beta-Guttiferrin) 抑制 Bcl-XLBcl-2Bcl-WBcl-BBfl-1Mcl-1IC50 分别为 1.47 μM,1.21 μM,2.02 μM,0.66 μM,1.06 μM 和 0.79 μM。
    Gambogic Acid (Standard)
  • HY-132997
    PROTAC Bcl-xL degrader-3 Inhibitor
    PROTAC Bcl-xL degrader-3 是一种有效的 PROTAC Bcl-xL 降解剂 (详细信息请参考 WO2020163823A2, compound 2)。
    PROTAC Bcl-xL degrader-3
  • HY-145826
    Mcl-1 inhibitor 8 Inhibitor
    Mcl-1 inhibitor 8 是一种 MCL-1 抑制剂,例 228,从专利 WO2019222112 中获得.
    Mcl-1 inhibitor 8
  • HY-169243
    BCL-XL-IN-1 Inhibitor
    BCL-XL-IN-1 (Compound 11) 是一种选择性 BCL-XL 抑制剂,对 BCL-XL TR-FERT 的 Ki <0.01 nM。BCL-XL-IN-1 可用于癌症研究。
    BCL-XL-IN-1
  • HY-169244
    CDK-TCIP1 Inhibitor
    CDK-TCIP1 是一种连接 CDK9 抑制剂 SNS-032 (HY-10008) 和 BCL6 配体 BI3812 (HY-111381) 的二价分子。CDK-TCIP1 能有效且特异性地杀死 BCL6 过表达细胞,对于 SUDHL5 细胞的 EC50 为 7.7 nM。
    CDK-TCIP1
  • HY-164452
    A-1155905
    A-1155905 是一种 MCL-1 抑制剂 (IC50=33.5 nM; Ki=0.58 nM),具有抗癌活性。A-1155905 选择性地与 MCL-1 结合,并具有足够的亲和力来破坏活细胞中的 MCL-1-bim 复合物。A-1155905 诱导的 MCL-1 依赖性细胞系的死亡依赖于半胱天冬酶蛋白 (caspase),并通过凋亡 (apoptosis) 发生。
    A-1155905
  • HY-163293
    Mcl-1 inhibitor 18 Inhibitor
    Mcl-1 inhibitor 18 (compound 57) 是一种髓细胞白血病 1 (Mcl-1) 抑制剂,可用于癌症研究。
    Mcl-1 inhibitor 18
  • HY-149623
    Bcl-2-IN-13 Inhibitor
    Bcl-2-IN-13 是一种 Bcl-2 抑制剂,IC50 值为 17 nM。Bcl-2-IN-13 可用于癌症的研究。
    Bcl-2-IN-13
  • HY-155012
    Mcl-1 inhibitor 16 Inhibitor
    Mcl-1 inhibitor 16 (Compound 9) 是一种基于铂的线粒体靶向 Mcl-1 抑制剂。Mcl-1 inhibitor 16 诱导癌细胞中 Bax/Bak 依赖性的细胞凋亡 (apoptosis)。apoptosis 可以单独使用或与ABT-199 (HY-15531)一起使用并显示出抗肿瘤活性。
    Mcl-1 inhibitor 16
  • HY-129702
    MCL-1/BCL-2-IN-4 Inhibitor
    MCL-1/BCL-2-IN-4 (Compound 7) 是一种有效的选择性 Mcl-1Bcl-2 抑制剂。
    MCL-1/BCL-2-IN-4
  • HY-P3148
    Astin B Modulator
    Astin B 是一种口服有效的环状五肽,可从 Aster tataricus 中分离得到。Astin B 在体外和体内均具有肝毒性作用,肝损伤主要由线粒体/半胱天冬酶依赖性方式的细胞凋亡 (apoptosis) 介导。Astin B 在 L-02 细胞中诱导自噬 (autophagy),增加 LC3-II 并降低 p62 表达。
    Astin B
  • HY-149624
    Bcl-2-IN-14 Inhibitor
    Bcl-2-IN-14 (Compound 13c) 是一种 BCL-2 抑制剂,IC50 值为 0.471μM。Bcl-2-IN-14 可用于癌症的研究。
    Bcl-2-IN-14
  • HY-169266
    BRD-K56819078 Inhibitor
    BRD-K56819078 是一种 Bcl-2 抑制剂,可显著降低肾脏中衰老细胞负荷和衰老相关基因的 mRNA 表达。BRD-K56819078 通过抑制细胞凋亡 (apoptosis) 发挥抗衰老作用。
    BRD-K56819078
  • HY-153423
    Mcl-1 inhibitor 12 Inhibitor
    Mcl-1 inhibitor 12 (Example 10) 是一种 MCL-1 抑制剂 (Ki: 0.22 nM)。Mcl-1 inhibitor 12 可用于癌症的研究。
    Mcl-1 inhibitor 12
  • HY-149622
    Bcl-2-IN-12 Inhibitor
    Bcl-2-IN-12 (Compound 1) 是一种 Bcl-2 抑制剂 (IC50: 6 nM)。Bcl-2-IN-12 可用于癌症研究。
    Bcl-2-IN-12
  • HY-146183
    BCL6-IN-9 Inhibitor
    BCL6-IN-9 (compound 1) 是一种有效的 B 细胞淋巴瘤 6 蛋白 (BCL6) 抑制剂,IC50 值为 3.9 nM。BCL6-IN-9 可用于癌症研究。
    BCL6-IN-9
  • HY-P5325F
    Bid BH3 (80-99), FAM labeled
    Bid BH3 (80-99), FAM labeled 是一种有生物活性的肽。(这是 5-FAM 标记的 Bid BH3 HY-P5325 肽。)
    Bid BH3 (80-99), FAM labeled
  • HY-13407S
    Gossypol-13C2
    Gossypol-13C2 (BL 193-13C2) 是一种活性化合物。 Gossypol-13C2 可用于各种研究。
    Gossypol-<sup>13</sup>C<sub>2</sub>
  • HY-RS01421
    BCL2L1 Human Pre-designed siRNA Set A Inhibitor
    BCL2L1 Human Pre-designed siRNA Set A 包括针对 BCL2L1 (Human) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    BCL2L1 Human Pre-designed siRNA Set A
    BCL2L1 Human Pre-designed siRNA Set A
  • HY-161659
    Apoptosis inducer 19 Modulator
    Apoptosis inducer 19 (Compound 7g) 是一种凋亡 (apoptosis) 诱导剂。Apoptosis inducer 19 可提高促凋亡蛋白 (Baxcaspase-3)的表达并下调抗凋亡蛋白 (Bcl-2)。Apoptosis inducer 19 可上调细胞活性氧 (ROS) 水平并破坏线粒体膜电位 (MMP)。Apoptosis inducer 19 可用于三阴性乳腺癌 (TNBC) 研究。
    Apoptosis inducer 19
目录号 产品名 / 同用名 应用 反应物种

Bcl-2 family members have been grouped into three classes. The anti-apoptotic subfamily contains the Bcl-2, Bcl-XL, Bcl-w, Mcl-1, Bfl1/A-1, and Bcl-B proteins, which suppress apoptosis and contain all four Bcl-2 homology domains, designated BH1-4. The pro-apoptotic subfamily contain BH1-3 domains, such as Bax, Bak, and Bok. A third class of BH3 only proteins Bad, Bid, Bim, Noxa and Puma have a conserved BH3 domain that can bind and regulate the anti-apoptotic BCL-2 proteins to promote apoptosis [1].


The intrinsic pathway is initiated by various signals, principally extracellular stimuli. BH3-only proteins (Bim, Bid, Bad, Noxa, Puma) engage with anti-apoptotic Bcl-2 family proteins to relieve their inhibition of Bax and Bak to activate them. Next, Bax and Bak are oligomerized and activated, leading to mitochondrial outer membrane permeabilization. Once mitochondrial membranes are permeabilized, cytochrome c and/or Smac/DIABLO is released into the cytoplasm, wherein they combine with an adaptor molecule, Apaf-1, and an inactive initiator Caspase, Pro-caspase 9, within a multiprotein complex called the apoptosome. Smac/DIABLO inhibits IAPs to activate Caspase 9. Caspase 9 activates Caspase 3, which is the initiation step for the cascade of Caspase activation. The extrinsic pathway can be activated by cell surface receptors, such as Fas and TNF Receptor, subsequently activating Caspase 8, and leads to Caspase 3 activation and cell demolition. Caspases in turn cleave a series of substrates, activate DNases and orchestrate the demolition of the cell. Bcl-2 family proteins are also found on the endoplasmic reticulum and the perinuclear membrane in hematopoietic cells, but they are predominantly localized to mitochondria [2]

 

Reference:
[1]. Cotter TG, et al. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009 Jul;9(7):501-7.

[2]. Kang MH, et al. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009 Feb 15;15(4):1126-32.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.